Two weeks after Donald Trump announced he was going to lower drug prices from anywhere from 30% to 90%, there still haven't been any deals made. 

But more than that, what he wants to do, something called Most Favored Nation status, is bad policy, especially when it comes to drug prices. 

Grant is joined by Yale Economist Jason Abaluck to talk about why Trump's plan to lower drug prices won't lower them, might raise prices, could stifle medical innovation at home and abroad, and what that means for your next prescription. 

LINKS:

Jason Abaluck's Research

Support the show

Follow along on social media

X: @mimsnewspod
Instagram: @mimsnewspod
TikTok: @mimsnewspod
Substack: mimsnewspod.substack.com
YouTube: youtube.com/@MIMSnewspod
Bluesky: Granthermes.bsky.social

Follow Grant:
X: @GrantHermes
Insta/TikTok: GrantHermesTV

SPONSORS AND ADS:
Our listeners are smart, loyal, and tuned in — and your brand could be too.
Let’s work together. For sponsorships and custom ad spots, reach out to [email protected]